Mode
Text Size
Log in / Sign up
N/A N=20 Treatment

The Use of an "Anal-Tape" in Patients With Fecal Incontinence

Fecal Incontinence

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs) — 2.8; 3.3; 1.9; 2.5 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Anal Tape (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Shaare Zedek Medical Center
Primary completion
Dec 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)
2.8; 3.3; 1.9; 2.5; 3.1; 3.5
SECONDARY
A 50% Reduction in the Number of Episodes of FI Per Week
0; 5
SECONDARY
Mean Wexner Score
11.9; 10.3
SECONDARY
Mean Redction in Wexner Scale Compared to Baseline
0.6; 1.95
SECONDARY
General Satisfaction
80
SECONDARY
Willingness of the Patient to Continue Using the Anal Tape After the Study.
90

Summary

Fecal incontinence (FI), defined as the involuntary passage of stool for more than 3 months and is a devastating disease. The negative impact on quality of life has been consistently demonstrated. The prevalence of FI is probably underestimated in most studies. Currently conservative treatment is only modestly effective and surgical treatment is complex and expensive with less than optimal efficacy. The investigators developed an "anal tape" using a commercially available elastic band with a special adhesive that is approved for use in the skin. A special design of the tape can be applied to the skin surrounding the anus providing support and additional pressure forces to the anal sphincter. This is a 4 week, prospective, non blinded, cross-over study to explore the efficacy and safety of this device in patients with FI. The primary endpoint will be improvement in quality of life.

Eligibility Criteria

Inclusion Criteria

  • >18 years old
  • Fecal incontinence for more than 6 months
  • Willing to participate
  • Understand the study procedures
  • Is able to apply and remove the "anal tape" without significant assistance of others.
  • Have done sigmoidsocopy or colonoscopy and anal manometry within five year of screening visit

Exclusion Criteria

  • Advanced full thickness rectal prolapse.
  • Injured, inflamed or any significant disease in the peri-anal skin.
  • Allergy to any component of the device, either known or developed during testing in the screening visit.
  • Moderate to severe proctitis of any etiology.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02989545). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search